http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100472086-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 |
| filingDate | 2001-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100472086-B1 |
| titleOfInvention | 3,5-Dialkoxy-4-hydroxyphenyl substituted piperazine derivatives as antioxidants, process for preparing thereof and pharmaceutical compositions containing them |
| abstract | The present invention relates to a piperazine derivative substituted with a 3,5-dialkoxy-4-hydroxyphenyl group having excellent antioxidant activity, a method for preparing the same, and a pharmaceutical composition comprising the same. Piperazine derivatives substituted with 3,5-dialkoxy-4-hydroxyphenyl groups have not only superior antioxidant activity and low toxicity compared to conventional antioxidant compounds, but also anti-aging agents, cancer, diabetes and epilepsy treatments, and dementia, par It can be usefully used as a therapeutic agent for neurodegenerative diseases of Kinson's disease, stroke and Huntington.nn n n Formula 1nn n n n n n n n (Wherein R, X and Y are as described in the specification). |
| priorityDate | 2001-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.